JANX - Janux Therapeutics - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

JANX is currently covered by 2 analysts with an average price target of $64.26. This is a potential upside of $13.71 (27.12%) from yesterday's end of day stock price of $50.55.

Janux Therapeutics's activity chart (see below) currently has 1 price targets and 11 ratings on display. The stock rating distribution of JANX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 92.86% with an average time for these price targets to be met of 294.5 days.

Highest price target for JANX is $50, Lowest price target is $24, average price target is $64.26.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 11-Mar-2024. First documented stock forecast 13-Mar-2023.

Best performing analysts who are covering JANX - Janux Therapeutics:

Swayampakula Ramakanth Robert Driscoll

Currently out of the existing stock ratings of JANX, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

50

$11.37 (29.43%)

35

1 months 8 days ago

6/7 (85.71%)

$10.03 (25.09%)

357

Buy

24

$-14.63 (-37.87%)

24

5 months 11 days ago

5/5 (100%)

$17.38 (262.54%)

232

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JANX (Janux Therapeutics) average time for price targets to be met?

On average it took 294.5 days on average for the stock forecasts to be realized with a an average price target met ratio 92.86

Which analyst has the current highest performing score on JANX (Janux Therapeutics) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on JANX (Janux Therapeutics) with a proven track record?

ROBERT DRISCOLL

Which analyst has the most public recommendations on JANX (Janux Therapeutics)?

Swayampakula Ramakanth has 4 price targets and 4 ratings on JANX

Which analyst is the currently most bullish on JANX (Janux Therapeutics)?

Swayampakula Ramakanth with highest potential upside - $11.37

Which analyst is the currently most reserved on JANX (Janux Therapeutics)?

Robert Driscoll with lowest potential downside - -$14.63

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?